Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.06 - $0.27 $6 - $27
100 New
100 $0
Q2 2023

Aug 14, 2023

BUY
$0.35 - $0.82 $10 - $24
30 New
30 $0
Q2 2022

Aug 15, 2022

SELL
$2.66 - $5.81 $699 - $1,528
-263 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$6.0 - $10.0 $1,578 - $2,630
263 New
263 $2,000

Others Institutions Holding LMDX

About LumiraDx Ltd


  • Ticker LMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 170,688,000
  • Market Cap $1.71M
  • Description
  • LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...
More about LMDX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.